Topic: molecule design
-
Chai Discovery Raises $130M Series B at $1.3B Valuation
Chai Discovery secured $130 million in Series B funding, reaching a $1.3 billion valuation, with investment led by top venture capital firms. The company develops AI foundation models to predict molecular interactions and accelerate drug discovery, notably in *de novo* antibody design. Its latest...
Read More »